UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028877
Receipt number R000033050
Scientific Title Dexamethasone for cancer-related fatigue in advanced cancer patients - multi-center phase II trial
Date of disclosure of the study information 2017/08/31
Last modified on 2023/09/03 09:16:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Dexamethasone for cancer-related fatigue in advanced cancer patients - multi-center phase II trial

Acronym

Dexamethasone for cancer-related fatigue in advanced cancer patients - multi-center phase II trial

Scientific Title

Dexamethasone for cancer-related fatigue in advanced cancer patients - multi-center phase II trial

Scientific Title:Acronym

Dexamethasone for cancer-related fatigue in advanced cancer patients - multi-center phase II trial

Region

Japan


Condition

Condition

cancer (cancer-related fatigue)

Classification by specialty

Medicine in general Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To reveal the efficacy of dexamethasone 8mg p.o or 6.6mg i.v. for moderate to severe cancer-related fatigue

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The change of FACIT-Fatigue subscale score at day 8

Key secondary outcomes

The change of fatigue score
The proportion of achievement of individual therapeutic goal
The change of symptom scores
the change of performance status
Patients satisfaction
Adverse events


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

1. Dexamethasone 8mg by mouth once a day day 1-7, 4mg for day 8-14
2. Dexamethasone 6.6mg by venous injection once a day day 1-7, 3.3mg for day 8-14

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

A diagnosis of advanced cancer (defined as metastatic or recurrent) with fatigue score 4 and more using NRS(0-10)
20 years and older
Prognosis over 30 days
No anti-cancer treatment plan
Inpatient receiving palliative care
Performance status 0-3
Conprehension of Japanese
Provided written informed consent

Key exclusion criteria

Patients received corticosteroid therapies within 1 week
Patients received surgery within 4 week
Patients received radiation therapy within 2 week
Patients received anti-tumor treatment within 2 week
Patients had diabetes mellitus, active infection and cognitive disorder



Target sample size

32


Research contact person

Name of lead principal investigator

1st name Tomofumi
Middle name
Last name Miura

Organization

National Cancer Center Hospital East

Division name

Department of Palliative Medicine

Zip code

2778577

Address

Kashiwanoha 6-5-1, Kashiwa-city, Chiba-prefecture

TEL

04-7133-1111

Email

tomiura@east.ncc.go.jp


Public contact

Name of contact person

1st name Tomofumi
Middle name
Last name Miura

Organization

National Cancer Center Hospital East

Division name

Department of Palliative Medicine

Zip code

2778577

Address

Kashiwanoha 6-5-1, Kashiwa-city, Chiba-prefecture

TEL

04-7133-1111

Homepage URL


Email

tomiura@east.ncc.go.jp


Sponsor or person

Institute

National Cancer Center Hospital East

Institute

Department

Personal name



Funding Source

Organization

AMED(Japan)

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB for National Cancer Center

Address

Kashiwanoha 6-5-1, Kashiwa, Chiba

Tel

0471331111

Email

not@released.


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 08 Month 31 Day


Related information

URL releasing protocol

Please see (https://www.liebertpub.com/doi/full/10.1089/pmr.2021.0053)

Publication of results

Published


Result

URL related to results and publications

Please see (https://www.liebertpub.com/doi/full/10.1089/pmr.2021.0053)

Number of participants that the trial has enrolled

32

Results

Please see the abstract (https://www.liebertpub.com/doi/full/10.1089/pmr.2021.0053)

Results date posted

2023 Year 09 Month 03 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Please see the abstract (https://www.liebertpub.com/doi/full/10.1089/pmr.2021.0053)

Participant flow

we enrolled participants in 5 institutes

Adverse events

Please see the abstract (https://www.liebertpub.com/doi/full/10.1089/pmr.2021.0053)

Outcome measures

Please see the abstract (https://www.liebertpub.com/doi/full/10.1089/pmr.2021.0053)

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 06 Month 05 Day

Date of IRB

2017 Year 06 Month 05 Day

Anticipated trial start date

2017 Year 10 Month 01 Day

Last follow-up date

2019 Year 12 Month 04 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 08 Month 29 Day

Last modified on

2023 Year 09 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033050


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name